The PE Ratio as of September 2024 (TTM) for ACADIA Pharmaceuticals Inc. (ACAD) is 84.58

According to ACADIA Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 84.58. This represents a change of 320.97% compared to the average of 20.09 of the last 4 quarters.

ACADIA Pharmaceuticals Inc. (ACAD) Historical PE Ratio (quarterly & annually)

How has ACAD PE Ratio performed in the past?

The mean historical PE Ratio of ACADIA Pharmaceuticals Inc. over the last ten years is -26.32. The current 84.58 PE Ratio has changed -32237.51% with respect to the historical average. Over the past ten years (40 quarters), ACAD's PE Ratio was at its highest in in the June 2023 quarter at 878.55. The PE Ratio was at its lowest in in the September 2021 quarter at -46.15.

ACADIA Pharmaceuticals Inc. (ACAD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ACADIA Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ACADIA Pharmaceuticals Inc. (ACAD) Average PE Ratio

How has ACAD PE Ratio performed in the past?

The current PE Ratio of ACADIA Pharmaceuticals Inc. (ACAD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ACADIA Pharmaceuticals Inc. (ACAD) PE Ratio vs. Peers

How is ACAD’s PE Ratio compared to its peers?

ACADIA Pharmaceuticals Inc.’s PE Ratio is greater than Madrigal Pharmaceuticals, Inc. (-10.23), greater than Viking Therapeutics, Inc. (-61.76), less than Sarepta Therapeutics, Inc. (257.91), greater than Hepion Pharmaceuticals, Inc. (-0.15), greater than PTC Therapeutics, Inc. (-5.05), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.10), greater than Athira Pharma, Inc. (-0.18), greater than Fortress Biotech, Inc. (-0.71), greater than Cabaletta Bio, Inc. (-2.34), greater than Intercept Pharmaceuticals, Inc. (-13.55), greater than Terns Pharmaceuticals, Inc. (-6.06), greater than Akero Therapeutics, Inc. (-8.95), greater than Reata Pharmaceuticals, Inc. (-89.36), greater than Krystal Biotech, Inc. (49.72), greater than Blueprint Medicines Corporation (-26.44),

Build a custom stock screener for ACADIA Pharmaceuticals Inc. (ACAD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ACADIA Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ACADIA Pharmaceuticals Inc. (ACAD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ACADIA Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.